The Synergistic Combination of the Farnesyl Transferase Inhibitor Lonafarnib and Paclitaxel Enhances Tubulin Acetylation and Requires a Functional Tubulin Deacetylase

Lignende værker

• Farnesyl Transferase Expression Determines Clinical Response to the Docetaxel-Lonafarnib Combination in Patients with Advanced Malignancies
  af: Kauh, John, et al.
  Udgivet: (2011)
• Resistance to Microtubule-Stabilizing Drugs Involves Two Events β-Tubulin Mutation in One Allele Followed by Loss of the Second Allele
  af: Wang, Yuefang, et al.
  Udgivet: (2005)
• Microtubule disruption targets HIF-1α mRNA to cytoplasmic P-bodies for translational repression
  af: Carbonaro, Marisa, et al.
  Udgivet: (2011)
• Peloruside- and Laulimalide-Resistant Human Ovarian Carcinoma Cells Have βI-Tubulin Mutations and Altered Expression of βII- and βIII-Tubulin Isotypes
  af: Kanakkanthara, Arun, et al.
  Udgivet: (2011)
• Microtubules Regulate Hypoxia-inducible Factor-1α Protein Trafficking and Activity: IMPLICATIONS FOR TAXANE THERAPY
  af: Carbonaro, Marisa, et al.
  Udgivet: (2012)